Genetic alterations in brain tumors identified by RAPD analysis

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Meningiomas and gliomas are primary brain tumors with distinct genetic profiles.
• Identifying genomic alterations is crucial for understanding tumor development and progression.
• Existing DNA fingerprinting methods have limitations in detecting subtle genomic changes.

Purpose of the Study:

• To evaluate the utility of Random Amplified Polymorphic DNA (RAPD) analysis for detecting genomic alterations in meningiomas and gliomas.
• To compare the DNA band profiles of tumor tissue with constitutional DNA to identify genetic variations.
• To assess the sensitivity and scope of RAPD analysis in detecting subtle genomic changes within a specific size range.

Main Methods:

• Random Amplified Polymorphic DNA (RAPD) analysis was performed on DNA extracted from meningioma and glioma tumor samples and their constitutional counterparts.
• A panel of GC-rich decanucleotide random primers was used to amplify specific DNA fragments.
• DNA band profiles were compared between tumor and constitutional DNA to identify alterations, including band loss, appearance, or amplification.

Main Results:

• RAPD analysis revealed genomic alterations in a significant proportion of both meningioma and glioma samples.
• Twenty out of 29 primers detected alterations in meningiomas, while 16 out of 18 primers detected changes in gliomas.
• Alterations observed included loss of normal bands, appearance of new bands, and amplification of existing bands, with some primers detecting multiple changes per tumor.

Conclusions:

• RAPD analysis is a valuable tool for identifying subtle genomic alterations in meningiomas and gliomas.
• This method complements existing DNA fingerprinting techniques like microsatellite mapping and Southern blotting by covering a DNA fragment size range of 0.4 to 2 kb.
• RAPD analysis provides a sensitive approach for detecting genetic changes across a spectrum of brain tumors.